Form 8-K TENET HEALTHCARE CORP For: Feb 12
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Tenet Healthcare (THC) PT Lowered to $185 at Raymond James, 'Selloff After Quarter is Perplexing — Creates Attractive Entry Point Despite Policy Risks'
February 13, 2025 8:45 AM ESTRaymond James analyst John Ransom lowered the price target on Tenet Healthcare (NYSE: THC) to $185.00 (from $195.00) while maintaining a Outperform rating.
The analyst comments "We reiterate our Outperform rating on shares of THC while lowering our price target to $185 (8.5x 2026 EBITDA ex-NCI) following 4Q24 results that were slightly... More
